WASHINGTON — A senior Food and Drug Administration official who played a pivotal role in the agency’s controversial handling of the diabetes pill Rezulin has resigned his post and temporarily assumed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback